Optimal MTX Dose With Folic Acid Randomized Case-control Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rheumatoid Arthritis
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04066803
- Collaborators
- Shanghai Pharmaceuticals Holding Co., Ltd
- Investigators
- Study Director: Yun Feng Pan, Master the 3rd Hospital of Sun Yat-sen University